The industry needs to more clearly define the different competencies and career paths within clinical research so all employees can lean into their strengths and build a career plan that brings them fulfillment.
Laboratory testing and clinical trial services giant LabCorp plans to spin off its drug development business as an independent, publicly traded company. It’s the latest in a string of corporate moves for the life sciences sector as companies look to streamline operations in order to focus on particular areas of growth.
A new report from Relatient, A Data-Driven Guide to Patient Access Succes, highlights how focusing on data accuracy and relevance can enhance the performance of healthcare practices.
Four years after a private equity acquisition took Parexel private, the contract research organization is being acquired by two private equity firms for $8.5 billion. It’s the latest in a series of acquisitions to hit the CRO sector this year.
Thermo Fisher Scientific sells laboratory equipment used in drug research and it also offers manufacturing services for experimental and commercialized drugs. By acquiring PPD, Thermo Fisher says it will gain capabilities in the growing global market of clinical trial services.
The contract research organization's announcement came as clinical trial sites anticipate significant disruption due to the pandemic, while the FDA has issued guidelines for running trials virtually.
Parexel, one of the largest CROs in the world, said the partnership would involve connecting real-world data across the clinical trials it conducts.
Choosing the right software translates directly into better client management, operational efficiency and growth for your spa franchise. Discover which tool is best for your business.
Judy Smythe, Bardia Akbari and Niv Caviar have been named as the company's chief operating officer, senior vice president of clinical operations and chief financial officer, respectively.
The report, by CRO Worldwide Clinical Trials, shows growing need for early-stage development expertise, with high demand for data quality, efficiency and overall trial management.
Growth in the CRO sector is expected to accompany growth of clinical trials, their complexity and regulatory requirements.
Dr. Todd Rothenhaus talks about the move from a large health IT vendor to a scrappy startup in his new role at Philadelphia startup The One Health Company.
Patient expectations continue to evolve, and healthcare practices that fail to adapt risk more than just revenue—they risk losing trust.
With the $1.7 billion acquisition of CRO and manufacturing company Lake Region Medical, Texas-based CRO Greatbatch has become one of the largest medtech-focused CROs in the world.
Paragon Bioservices – a contract research and manufacturing organization, has closed a $13 million round of Series A financing. The Baltimore company’s focused on biologics and vaccine work. The financing was led by NewSpring Capital and Camden Partners. Paragon CEO Marco Chacon described the fundraise as indicative of “an inflection point for the company,” now that […]